Diagnostic cut‐off values for the urinary corticoid:creatinine ratio for the diagnosis of canine Cushing's syndrome using an automated chemiluminescent assay
Veterinary Clinical Pathology · 2023
DOI: 10.1111/vcp.13219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Clinical Pathology, 2023. Verfasst von Ingo Schäfer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboklin GmbH & Co. KG, Bad Kissingen, Germany. Hauptthemen laut MEDLINE: Cushing Syndrome, Dog Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cushing's syndrome is one of the most common endocrinopathies in dogs. The preferred screening test for spontaneous Cushing's syndrome is the low‐dose dexamethasone suppression test (LDDST). The diagnostic value of urinary cortisol:creatinine ratio s (UCCR) is questionable.
Objectives
The aim of this study was to determine diagnostic cut‐off values for UCCR testing in comparison with LDDST as a clinical reference standard and to calculate the sensitivity and specificity.
Methods
Data from 2018 to 2020 were obtained retrospectively from a commercial laboratory. Both LDDST and UCCR were measured by automated chemiluminescent immunoassay (CLIA). The maximum interval between both tests was 14 days. The optimal cut‐off value for UCCR testing was calculated by the Youden index. The sensitivity and specificity of these cut‐off values for the UCCR test and LDDST were assessed by Bayesian latent class models (BLCMs).
Results
This study included 324 dogs with both UCCR test and LDDST results. The optimal UCCR cut‐off value, calculated by the Youden index, was 47.4 × 10 −6 . Any UCCR 60 × 10 −6 as positive. Using the cut‐off of 60 × 10 −6 , BLCM showed 91% (LDDST) and 86% (UCCR test) sensitivity and a specificity of 54% (LDDST) and 63% (UCCR test).
Conclusions
Considering an 86% sensitivity and a 63% specificity, UCCR testing may be considered a first‐line investigation to rule out Cushing's syndrome using CLIA analysis. Urine samples can be collected noninvasively at home by the owner, reducing the potential impact of stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboklin GmbH & Co. KG, Bad Kissingen, Germany.
- VETOS Tierklinik Berlin GmbH & Co. KG, Berlin, Germany.
- CRO Dr. med. Kottmann GmbH & Co. KG, Hamm, Germany.
ORCID-Profile: Ingo Schäfer
Zitieren
APA
Schäfer, I., Rehbein, S., Holtdirk, A., Kottmann, T., Klein, R., Müller, E., & Thoren-Tolling, K. (2023). Diagnostic cut‐off values for the urinary corticoid:creatinine ratio for the diagnosis of canine Cushing's syndrome using an automated chemiluminescent assay. Veterinary Clinical Pathology. https://doi.org/10.1111/vcp.13219
Vancouver
Schäfer I, Rehbein S, Holtdirk A, Kottmann T, Klein R, Müller E, et al. Diagnostic cut‐off values for the urinary corticoid:creatinine ratio for the diagnosis of canine Cushing's syndrome using an automated chemiluminescent assay. Veterinary Clinical Pathology. 2023. doi:10.1111/vcp.13219
BibTeX
@article{Schfer2023,
author = {Schäfer, Ingo and Rehbein, Sina and Holtdirk, Annette and Kottmann, Tanja and Klein, Ruth and Müller, Elisabeth and Thoren-Tolling, Kerstin},
title = {Diagnostic cut‐off values for the urinary corticoid:creatinine ratio for the diagnosis of canine Cushing's syndrome using an automated chemiluminescent assay},
journal = {Veterinary Clinical Pathology},
year = {2023},
doi = {10.1111/vcp.13219}
}
EUVIMED